HAL Id: hal-02936982
https://hal.archives-ouvertes.fr/hal-02936982
Submitted on 10 Oct 2020
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-entific research documents, whether they are pub-lished or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.
A randomised, placebo-controlled trial evaluating effects
of lebrikizumab on airway eosinophilic inflammation and
remodelling in uncontrolled asthma (CLAVIER).
Cary D Austin, Melissa-Gonzalez Edick, Ronald E. Ferrando, Margaret Solon,
Miriam Baca, Kathryn Mesh, Peter Bradding, Gail M. Gauvreau, Kaharu
Sumino, J Mark Fitzgerald, et al.
To cite this version:
Cary D Austin, Melissa-Gonzalez Edick, Ronald E. Ferrando, Margaret Solon, Miriam Baca, et al.. A randomised, placebo-controlled trial evaluating effects of lebrikizumab on airway eosinophilic in-flammation and remodelling in uncontrolled asthma (CLAVIER).. Clinical and Experimental Allergy, Wiley, In press, �10.1111/cea.13731�. �hal-02936982�